Roivant Sciences
ROIV
294 hedge funds and large institutions have $6.57B invested in Roivant Sciences in 2024 Q3 according to their latest regulatory filings, with 53 funds opening new positions, 124 increasing their positions, 68 reducing their positions, and 52 closing their positions.
82% more repeat investments, than reductions
Existing positions increased: 124 | Existing positions reduced: 68
14% more capital invested
Capital invested by funds: $5.77B → $6.57B (+$800M)
3.09% more ownership
Funds ownership: 73.88% → 76.97% (+3.1%)
2% more first-time investments, than exits
New positions opened: 53 | Existing positions closed: 52
0% more funds holding
Funds holding: 294 → 294 (0)
11% less funds holding in top 10
Funds holding in top 10: 19 → 17 (-2)
47% less call options, than puts
Call options by funds: $17.6M | Put options by funds: $33.3M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$381M |
| 2 |
BlackRock
New York
|
+$75M |
| 3 |
TCIM
TOMS Capital Investment Management
New York
|
+$45.7M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$45.6M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$29.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
-$171M |
| 2 |
SIAU
SB Investment Advisers (UK)
London,
United Kingdom
|
-$61.8M |
| 3 |
BI
BVF Inc
San Francisco,
California
|
-$29M |
| 4 |
Jane Street
New York
|
-$28.4M |
| 5 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$19.7M |
ROIV Hedge Fund Activity: Q3 2024 in Review
294 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Roivant Sciences (ROIV) for Q3 2024, worth a combined $6.57B — up 14% from $5.77B a quarter earlier.
Buyers outnumbered sellers: 53 funds opened new ROIV positions and 52 closed out — a net gain of 1 holder — while 124 added to existing stakes and 68 trimmed.
The largest buyer was Vanguard Group, adding an estimated $381M. The largest seller was Viking Global Investors, cutting an estimated $171M.
- 294 institutional investors held Roivant Sciences (ROIV) as of Q3 2024, unchanged from Q2 2024.
- Funds reported $6.57B of Roivant Sciences stock for Q3 2024, up 14% quarter-over-quarter.
- 53 funds opened new Roivant Sciences positions in Q3 2024 and 52 closed out, a net change of +1 holder.
- The largest Roivant Sciences buyer in Q3 2024 was Vanguard Group, an estimated $381M added.
- The largest Roivant Sciences seller in Q3 2024 was Viking Global Investors, an estimated $171M sold.
Based on aggregated 13F filings for Q3 2024.